Key considerations as a buyer from the manufacturing and legal perspective

Since the start of the Covid-19 pandemic, supply contracts have been under the spotlight like never before. Manufacturing deals have been closed between major pharma companies in record times, but not surprisingly as often happens for novel products, supply difficulties have arisen.

The AstraZeneca team will share their insights and experience in this critical business area during this 2 hour course.

Presented by:

Brian Dell, Operations Business Development Director

Nidhi Jain, Operations Procurement – Associate Director, External Commercial Manufacturing Therapy Area Lead

Adam McArthur, Assistant General Counsel, Digital, IT & Operations

Mike Stiles, Operations Business Development Director

Learning Objectives

• Importance of due diligence, and the role of Operations/Supply Chain at each phase
• Supply Agreements key contract clauses
• How to build flexibility and protections into a contract to manage fluctuations in demand/raw materials
• How to manage performance aspects
• Importance of relationships between buyer and manufacturer